A paper in press in the Journal of Urology has suggested that, for patients with intermediate-risk prostate cancer who elect treatment with a combination of standard (low dose) brachytherapy and external beam radiation therapy (EBRT), the addition of hormone therapy adds little in terms of clinical benefit.
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, combination radiotherapy, EBRT, external beam radiation therapy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
